Prime Therapeutics Expanding Formulary Exclusion Program In 2018
Executive Summary
The NetResults formulary contributed to a 0.2% decline in overall drug spending by the pharmacy benefit manager's commercial clients in 2017, according to Prime Therapeutics' Drug Trend report.